Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic (PK) Study of ASP8825 - Evaluation of Pharmacokinetics in Patients With Impaired Renal Function and Haemodialysis

NCT02629224 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT02629224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02629224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic (PK) Study of ASP8825 - Evaluation of Pharmacokinetics in Patients With Impaired Renal Function and Haemodialysis
Lead sponsor
Astellas Pharma Inc
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2008
Completion date
October 31, 2008
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

patients with impaired renal function and haemodialysis